Characteristics | Mean | SD |
Patients’ age | 65.1 | 11.1 |
Female gender (%) | 56.2 | |
VA (ETDRS letters) baseline | 75.8 | 9.7 |
Central macular thickness (CMT) (µm) baseline | 264.9 | 85.3 |
Mean changes in VA (ETDRS letters) from baseline | −4.2 | 9.3 |
Mean changes in CMT (µm) from baseline | 29.5 | 134.7 |
Ethnicity | n (eyes) | |
English/Welsh/Scottish/Northern Irish/British | 27 | |
Mixed/multiple ethnic groups | 2 | |
Any other white background | 6 | |
Indian | 15 | |
Pakistani | 12 | |
Any other Asian background | 1 | |
African | 4 | |
Caribbean | 9 | |
Any other Black/African/Caribbean background | 2 | |
Not stated | 20 | |
Diagnoses | n (eyes) | |
DMO | 57 | |
RVO | 14 | |
3-AMD | 9 | |
Diabetic maculopathy | 5 | |
Diabetic retinopathy no maculopathy | 7 | |
Sickle cell retinopathy | 1 | |
Atherosclerosis | 2 | |
Myopic CNV | 3 | |
Frequency of alarms | n (eyes) | |
1 | 70 | |
2 | 14 | |
3 | 5 | |
4 | 3 | |
5 | 3 | |
7 | 1 | |
8 | 1 | |
9 | 1 |
AMD, age-related macular degeneration; CMT, central macular thickness; CNV, choroidal neovascularisation; DMO, diabetic macular oedema; ETDRS, Early Treatment of Diabetic Retinopathy Study; RVO, retinal vein occlusion; VA, visual acuity.